While employers aren’t yet reimbursing weight loss drugs en masse, significantly reduced net costs could affect their future ...

Regeneron isn’t the only Big Pharma to spot potential in Hansoh’s obesity pipeline. Merck & Co. ended last year paying $112 ...

Ellie Crabtree, 22, from Cumbria, fell into a trap of emotional eating while caring for her father, Geoff, 59, was diagnosed ...

Drug-induced liver injury cases are increasing, with common medications and supplements posing hidden dangers, especially for ...

Regeneron Pharmaceuticals has signed a new licensing agreement with Hansoh Pharmaceuticals Group to develop and sell its weight loss therapy outside of China.